📢InSyBio Suite Version 3.2 is released democratizing #singlecell #RNAsequencing analysis by allowing optimized elaborate analytics to non-bioinformatics experts through its web interface. The new version enables: -optimized analysis from raw data simplifying the process and ability to be run by non-bioinformatics experts. -Efficient #integration of multiple scRNAseq datasets, removing efficiently the technical biases and maintaining biological variability. -#Celldeconvolution of bulk transcriptomics and proteomics data using scRNAseq data. -Discovery and documentation of cell-cell communication patterns using CellChat workflow. -Discovery of single-cell trajectories and RNA-velocity patterns using scVelo workflow -Custom figure preparation and documented bioinformatics analysis integrated with additional tools of InSyBio Suite for #biomarkerdiscovery, #network and #AI / #machinelearning analysis. Read more details about these at: https://lnkd.in/enqnEUsV and request a free trial at: https://lnkd.in/ePZu9x6K #bioinformatics #webplatform #mapping #cellclustering #cellannotation #celltrajectories #cellcellcommunication
InSyBio
Biotechnology Research
Austin, Texas 3,491 followers
A disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning
About us
InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in discovering predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries. InSyBio has recently expanded its offering including a complete set of services that allows the personalization of nutrition, nutraceutical, vitamin and probiotic products. These services are built around InSyBio Personalization Test which allows predicting outcomes and satisfaction of each customer using specific products before even they purchase them. InSyBio has developed an online suite of software tools – called InSyBio Suite – which assists biology researchers in extracting valuable biological knowledge from experimental data. The 3 and 12-month licenses of the InSyBio Suite as well as free 1-month licenses of our platform are provided. InSyBio Suite consists of tools for providing integrated biological information from various sources, while at the same time it is empowered with robust, user-friendly and installation-free bioinformatics tools based on intelligent algorithms and methods. Some of its methodologies have already been published in international scientific journals and conferences while others are under submission for patent approval by its members. The use of InSyBio Suite for biomedical data analyses, reduces the time and cost requirements by at least 80%, increases predictive accuracy of outcome and diagnostic predictive models by at least 10% and allows biomarker and outcome models discovery in low sample size studies. Since June 2015 InSyBio participates in NBG Business Seeds program by National Bank of Greece. For more information about our company contact us at info@insybio.com.
- Website
-
https://www.insybio.com
External link for InSyBio
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Bioinformatics, Systems Medicine, Biomarkers Discovery, Gene Expression Data Analysis, Proteomics, Personalizednutrition, MachineLearning, and ArtificialIntelligence
Locations
-
Primary
2101 E. St. Elm
Bldg. 1, Ste. 100, Med2Market Offices
Austin, Texas TX 78744, US
-
Innovations House, 19 Staple Gardens, Winchester, Hampshire, S023 8SR
Winchester, Hampshire, Reg. No 8715590, GB
Employees at InSyBio
-
Christos Alexakos
Dr., Senior Software Engineer, Co-Founder InSyBio Ltd., Assistant Researcher at ISI/ATHENA RC
-
Konstantinos Theofilatos
CTO at InSyBio | Personalized Medicine & Nutrition, Biodata Analysis
-
Joanna Papanikolaidi
Software Engineer at InSyBio
-
Aigli Korfiati
Senior Machine Learning Researcher at Deeplab
Updates
-
We are excited to see the results of this great collaboration with Syndesis Health leading to the generation of two highly innovative products that can be used to personalize the treatment protocol and predict future outcomes for congestive heart failure and hypertrophic cardiomyopathy patients. These two products are now presented in the Abu Dhabi Global Healthcare Week (https://www.adghw.com/) while they are accessible via our newly launched InSyBio Diagnostics Platform (https://lnkd.in/efMw_k6x ) #MedicalAI #PrecisionMedicine #CardiovascularResearch
Very pleased to announce the first results of our collaboration with biotech innovators InSyBio. Using a curated dataset of cardiovascular patients on Syndesis Health data platform we developed a pair of powerful AI tools that optimise therapeutic protocols for congestive heart failure (CHF) and hypertrophic cardiomyopathy (HCM) to significantly reduce risk of complications to patients. Read the post to learn more... #RWE #MedicalAI
Syndesis Data Employed by Insybio's Predictive AI for Cardio
https://syndesis.com
-
🎉 We're glad to announce the upcoming presentation of Harry Zaverdas at 12o Forum Ygeias. Join us there to learn about valuable insights on our company’s role in personalizing #Healthcare and #Nutrition through #AI and how our technology can be used in the study of #AgingBone. We are waiting for you on Friday 10th at 12:00-14:00 (Athens GTM+3) in My Way Hotel, Patras or attend virtually live at the Forum’s website at: https://forumanaptixis.gr/
heading 1
forumanaptixis.gr
-
We are #hiring! We are seeking a talented junior software engineer with a Bachelor’s Diploma in Computer Engineering or any related diploma to work at our premises in Patras Science Park ( Επιστημονικό Πάρκο Πατρών), in Patras, Greece. The hired person will join our interdisciplinary team and work on the development and support of back-end functionalities of our biomedical data analysis platform, InSyBio Suite. The person who will be hired should participate in the Marie Skłodowska-Curie Actions (MSCA) grant OsteoNet (https://lnkd.in/e_g9wCqh) and conduct secondments in Italy & Belgium at the academic partners of the consortium. See details for this position at: https://lnkd.in/eVHGAGvP and send us your CV to consider you for this post at: careers@insybio.com #hiringnow #dataanalysis #juniorengineer #bioinformatics #machinelearning
Position 1: Junior Software Engineer Developer
https://insybio.com
-
InSyBio reposted this
Serial Entrepreneur 💡 Investor 🌱 Keynote Speaker 🗣️ Bestselling Author 📚 Mentor 🧭 Space Tech 🚀 Deep Tech 🤖
⚡️⚡️⚡️⚡️⚡️ The Super-Entrepreneurship Monday Post ⚡️⚡️⚡️⚡️⚡️ ✅ Tip of the week Why we should invest more in the convergence of AI and biotech. 🧬💻 By marrying AI's predictive prowess with biotech's life-altering innovations, we're on the cusp of unlocking solutions to some of humanity's most pressing challenges. 🌍❤️ This journey into AI-driven biotechnological innovation will foster a healthier, smarter, and more sustainable world for generations to come. 🌱🔬 👉 Want to know more? Read my latest article: https://lnkd.in/ehxiw2Q6 ✅ Quote of the week "Biotechnology and AI have the potential to resurrect the dreams of the past as well as create hopes for the future. As we blend these technologies, we are essentially reprogramming the world for a better tomorrow." - Ray Kurzweil, Inventor and Futurist ✅ Question of the week If you are working in the field of medicine or healthcare, which crazy idea leveraging AI could lead to a real breakthrough? Build the world you love. Fabrice 🙏🏽 Like it? Then, please share it with someone who needs to see it. 🙏🏽 #fabricetesta #AI #Biotech #Innovation #HealthTech #InvestmentJourney 🔥 Some useful links in the comments here below ⬇️
-
💡Single-cell technologies are here to stay. Among other challenges, the single-cell data analysis is far from being standardized with many open issues, such as handling data scarcity, identifying cells and cell communication patterns, retrieving cell trajectories and using single-cell data to deconvolve bulk omics data, not yet been fully elucidated. This great review suggests comprehensive best practices for data analysis and experimental protocol design for single-cell applications across different omics modalities. https://lnkd.in/g7TEw432 #research #singlecell #singlecellanalysis #scRNAseq
Best practices for single-cell analysis across modalities - Nature Reviews Genetics
nature.com
-
It was our pleasure to be presented today at the Loyal VC Portfolio Showcase online event. Great companies and teams with innovative solutions for diverse industries were presented to an audience of investors across the world. Contact us to get more details for our current financial round. #fundraising #startups #angelinvesting #venturecapital #investmentopportunity
Loyal VC Portfolio Showcase: December 11th at 10:00 EST / 16:00 CET Discover promising investment prospects on December 11th as we highlight a curated lineup of companies that have successfully secured multiple rounds of funding from Loyal. These companies represent diverse industries and are poised for substantial growth. Presenters: - CurveBlock, founded by Gary Woodhead FRSA - InsureHero, founded by Diego A. Roman - Umni no-code AI chatbot platform, founded by Elitza (Elly) Stoilova - Moduly, founded by Jonathan Lamer - InSyBio, founded by Konstantinos Theofilatos & Labros Digonis - GoFloaters, founded by Shyam Sundar Nagarajan - Kaabil Kids, founded by Sunil Raina Register here: https://lnkd.in/gNzgg6EM #venturecapital #angelinvesting #fundraising #investmentopportunity
Loyal VC Founder Showcase
loyal.vc
-
InSyBio reposted this
Congratulations to InSyBio for winning "Best Start-Up Initiative in 2023" at the CPHI Pharma Awards! InSyBio's groundbreaking work in targeted biomarker discovery and highly accurate predictive analytics impressed judges, offering a revolutionary impact on medical, clinical trials, and food/nutrition sectors. For more Loyal portfolio news, visit: https://lnkd.in/gimekqR6 Labros Digonis Konstantinos Theofilatos #venturecapital #angelinvesting #biomarkers #tech #ai #startupsuccess
"InSyBio impressed the judges reviewing the brand-new Start-Up Initiative category for its ability to revolutionize the medical field, clinical trials and food/nutrition industries through its targeted biomarker discovery. They have developed highly accurate predictive analytics enabling personalization of tests for drugs, nutraceuticals and nutrition products. Its solutions provide the R&D departments of Pharma, Research Institutes and Food/Nutrition companies with the means both analytically and computationally to meet their challenging research and innovation goals.", statement at the CPHI awards 2023 press release (https://lnkd.in/eyH3VexX). InSyBio was recognized as the best Start-Up Initiative in 2023 at CPHI Pharma Awards! CPHI is the biggest worldwide exhibition and event for the Pharma Industry and is organised annually and the CPHI Pharma Awards recognise progress and innovation across the pharma supply chain. Read more details about our announcement for winning this award at: https://lnkd.in/eWduETpt At InSyBio we are personalizing pharma and nutrition products using #AI with benefits for both the companies and the consumers/patients. #CPHI #innovation #CPHIPharmaAwards #precisionmedicine #personalizednutrition #technology #pharma #cphibarcelona #startup
InSyBio recognized as the best Start-Up Initiative in 2023 at CPHI Pharma Awards
http://insybio.wordpress.com
-
InSyBio reposted this
The Industrial Systems Institute / Research Centre ATHENA hosted on November 3, 2023 the final event of project VIRTUOUSH2020 at the premises of the "Athena" Research and Innovation Center in Athens. The event provided a good opportunity to present the final outcomes of the Virtuous project as well as network with SMEs and other projects in the domain of food. The Virtuous project has developed an integrated computational framework with the ability to screen food according to their components and make a classification of their expected taste, thus functioning as a “virtual tongue”. The platform has a potential for being used as a taste predictor in the food industry, precision agriculture, and as a link to neuroscience for taste determination. The platform is available at https://lnkd.in/dfkRhkJC while full information on the project can be found at https://virtuoush2020.com/ Invited talks in the event were given by the Università degli Studi di Firenze on the contribution of sensory science to food perception and preference, VINHOOD on taste profiling, Fitly on the future of personalized nutrition, ATHENA Research Center on GRE Taste project, and the University of the Aegean on food waste.
-
"InSyBio impressed the judges reviewing the brand-new Start-Up Initiative category for its ability to revolutionize the medical field, clinical trials and food/nutrition industries through its targeted biomarker discovery. They have developed highly accurate predictive analytics enabling personalization of tests for drugs, nutraceuticals and nutrition products. Its solutions provide the R&D departments of Pharma, Research Institutes and Food/Nutrition companies with the means both analytically and computationally to meet their challenging research and innovation goals.", statement at the CPHI awards 2023 press release (https://lnkd.in/eyH3VexX). InSyBio was recognized as the best Start-Up Initiative in 2023 at CPHI Pharma Awards! CPHI is the biggest worldwide exhibition and event for the Pharma Industry and is organised annually and the CPHI Pharma Awards recognise progress and innovation across the pharma supply chain. Read more details about our announcement for winning this award at: https://lnkd.in/eWduETpt At InSyBio we are personalizing pharma and nutrition products using #AI with benefits for both the companies and the consumers/patients. #CPHI #innovation #CPHIPharmaAwards #precisionmedicine #personalizednutrition #technology #pharma #cphibarcelona #startup
InSyBio recognized as the best Start-Up Initiative in 2023 at CPHI Pharma Awards
http://insybio.wordpress.com